GlassScriptPhysician profile
Gopal S Grandhige
NPI 1285816637
$93,348.75
in general payments reported to CMS, 2019-2025
22 companies · $6,362 in 2025
The $6,362 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49K · 2020: $14K · 2021: $11K · 2022: $4,608 · 2023: $6,677 · 2024: $1,576 · 2025: $6,362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $938 · Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,272.38 |
| Travel and Lodging | $937.55 |
| Food and Beverage | $405.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $44,320.17 | 2019-2023 | Echelon Flex, Linx Reflux Management System |
| Medical Device Business Services, INC. | $34,296.91 | 2019-2025 | |
| Intuitive Surgical, INC. | $6,736.28 | 2019-2021 | |
| Ethicon INC. | $2,788.13 | 2019 | |
| Depuy Synthes Sales INC. | $2,700.00 | 2021 | |
| Apollo Endosurgery US INC | $1,747.87 | 2021-2022 | |
| Endogastric Solutions, INC | $144.90 | 2019-2023 | Esophyx |
| Tela Bio, INC. | $139.09 | 2021 | |
| Galderma Laboratories, L.P. | $120.53 | 2023 | |
| Boston Scientific Corporation | $52.00 | 2019 | |
| Conmed Corporation | $51.56 | 2022 | |
| Medtronic Vascular, INC. | $46.65 | 2019 | |
| W. L. Gore & Associates, INC. | $42.46 | 2022 | |
| Vertical Pharmaceuticals, LLC | $24.84 | 2023 | Dsuvia |
| Karl Storz Endoscopy-America | $20.04 | 2025 | N.A. |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $20.02 | 2019 | |
| Lucid Diagnostics INC. | $18.99 | 2021 | |
| Baxter Healthcare | $17.41 | 2023 | Tisseel |
| Novo Nordisk INC | $16.32 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $15.84 | 2025 | Exparel |
| Davol INC. | $14.84 | 2023 | Phasix Mesh |
| Bolder Surgical LLC | $13.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gopal Grandhige listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.